Varicella Virus Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Evaluation of the Safety, Tolerability and Immunogenicity of VARIVAX ™ in Healthy Russians (V210-058)
Condition: Varicella Intervention: Biological: VARIVAX™ Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials
GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants
Condition: Infections, Meningococcal Interventions: Biological: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ); Biological: Prevnar13; Biological: Pediarix; Biological: Hiberix; Biological: Rotarix; Biological: M-M-R II; Biological: Varivax; Biological: Placebo (saline water) Sponsor: GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
